TY - JOUR
T1 - Toward a multi-level strategy to reduce stigma in global mental health: overview protocol of the Indigo Partnership to develop and test interventions in low- and middle-income countries
AU - Gronholm, Petra
AU - Bakolis, Ioannis
AU - Cherian, Anish V.
AU - Davies, Kelly
AU - Evans-Lacko, Sara
AU - Girma, Eshetu
AU - Gurung, Dristy
AU - Hanlon, Charlotte
AU - Hanna, Fahmy
AU - Henderson, Claire
AU - Kohrt, Brandon A
AU - Lempp, Heidi
AU - Li, Jie
AU - Loganathan, Santosh
AU - Maulik, Pallab K
AU - Ma, Ning
AU - Ouali, Uta
AU - Romeo, Renee
AU - Ruesch, Nicolas
AU - Semrau, Maya
AU - Taylor Salisbury, Tatiana
AU - Votruba, Nicole
AU - Wahid, Syed Shabab
AU - Zhang, Wufang
AU - Thornicroft, Graham
N1 - Funding Information: The Indigo Partnership research programme is a part of the Indigo Network; a collaboration of research colleagues in over 30 countries worldwide committed to developing knowledge about mental-illness-related stigma and discrimination, both in terms of their origins and their eradication. It is coordinated by the Centre for Global Mental Health, Institute of Psychiatry, Psychology and Neuroscience at King’s College London. We would like to acknowledge the contribution of our co-workers and collaborators Mirja Koschorke and Eva Heim. Funding Information: This work was supported by the UK Medical Research Council (MRC) [MR/R023697/1]. The funding body had no role in the design of the study, its data collection, analysis, and interpretation, or the writing of this manuscript. PCG is supported by the UK Medical Research Council (UKRI) in relation the Indigo Partnership (MR/R023697/1) award. IB is supported by the NIHR BRC at South London and Maudsley NHS Foundation Trust and King’s College London and by the NIHR Applied Research Collaboration South London (NIHR ARC South London) at King’s College Hospital NHS Foundation Trust. SEL also receives support from the Economic and Social Research Council, Global Challenges Research Fund Programme and the MRC Newton Fund Programme. DG is supported by the U.S. National Institute of Mental Health (Grant #: R01MH120649). CH is funded by the National Institute of Health Research (NIHR) Global Health Research Unit on Health System Strengthening in Sub-Saharan Africa, King’s College London (GHRU 16/136/54) and an NIHR RIGHT Grant (NIHR200842) using UK aid from the UK Government. The views expressed in this publication are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care. CH also receives support from AMARI as part of the DELTAS Africa Initiative [DEL-15–01]. BAK is supported by the U.S. National Institute of Mental Health (Grant #: R01MH120649). HL currently receives funding for successful Grants as a PI or co-PI: UKRCI Medical Research Council. JL is supported by Health and Family Planning Commission of Guangzhou Municipality, belonging to mental health model research in community of Guangzhou (Grant Number 2016A031002). PKM is the Principal Investigator on UK Research and Innovation (UKRI)/MRC Grant MR/S023224/1—Adolescents’ Resilience and Treatment nEeds for Mental health in Indian Slums (ARTEMIS) and Co-Principal Investigator on NHMRC/GACD Grant APP1143911—Systematic Medical Appraisal, Referral and Treatment for Common Mental Disorders in India—(SMART) Mental Health. MS is supported by the National Institute for Health Research Global Health Research Unit on NTDs at BSMS using Official Development Assistance funding. TTS is funded through a UKRI Future Leaders Fellowship (MR/T019662/1). NV is funded by the UK Medical Research Council (UKRI) in relation the Emilia (MR/S001255/1) and Indigo Partnership (MR/R023697/1) awards. The research was supported by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care South London at King’s College Hospital NHS Foundation Trust. GT is supported by the National Institute for Health Research (NIHR) Applied Research Collaboration South London at King’s College London NHS Foundation Trust, and by the NIHR Asset Global Health Unit award. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. GT is also supported by the Guy’s and St Thomas’ Charity for the On Trac project (EFT151101), and by the UK Medical Research Council (UKRI) in relation to the Emilia (MR/S001255/1) and Indigo Partnership (MR/R023697/1) awards. Funding Information: The Indigo Partnership is a five-year research programme ( http://www.indigo-group.org/indigo-partnership-research-programme/ ) that commenced in 2018, funded by the UK Medical Research Council [MR/R023697/1] []. The aims and objectives of the Indigo Partnership are summarised in Panel . The Indigo Partnership developed from the International Study of Discrimination and Stigma Outcomes (INDIGO) project—a long-standing global network of initiatives in stigma reduction [, , ]. Publisher Copyright: © 2023, The Author(s).
M1 - 2
PY - 2023/2/3
Y1 - 2023/2/3
N2 - There is increasing attention to the impacts of stigma and discrimination related to mental health on quality of life and access to and quality of healthcare. Effective strategies for stigma reduction exist, but most evidence comes from high-income settings. Recent reviews of stigma research have identified gaps in the field, including limited cultural and contextual adaptation of interventions, a lack of contextual psychometric information on evaluation tools, and, most notably, a lack of multi-level strategies for stigma reduction. The Indigo Partnership research programme will address these knowledge gaps through a multi-country, multi-site collaboration for anti-stigma interventions in low- and middle-income countries (LMICs) (China, Ethiopia, India, Nepal, and Tunisia). The Indigo Partnership aims to: (1) carry out research to strengthen the understanding of mechanisms of stigma processes and reduce stigma and discrimination against people with mental health conditions in LMICs; and (2) establish a strong collaborative research consortium through the conduct of this programme. Specifically, the Indigo Partnership involves developing and pilot testing anti-stigma interventions at the community, primary care, and mental health specialist care levels, with a systematic approach to cultural and contextual adaptation across the sites. This work also involves transcultural translation and adaptation of stigma and discrimination measurement tools. The Indigo Partnership operates with the key principle of partnering with people with lived experience of mental health conditions for the development and implementation of the pilot interventions, as well as capacity building and cross-site learning to actively develop a more globally representative and equitable mental health research community. This work is envisioned to have a long-lasting impact, both in terms of the capacity building provided to participating institutions and researchers, and the foundation it provides for future research to extend the evidence base of what works to reduce and ultimately end stigma and discrimination in mental health.
AB - There is increasing attention to the impacts of stigma and discrimination related to mental health on quality of life and access to and quality of healthcare. Effective strategies for stigma reduction exist, but most evidence comes from high-income settings. Recent reviews of stigma research have identified gaps in the field, including limited cultural and contextual adaptation of interventions, a lack of contextual psychometric information on evaluation tools, and, most notably, a lack of multi-level strategies for stigma reduction. The Indigo Partnership research programme will address these knowledge gaps through a multi-country, multi-site collaboration for anti-stigma interventions in low- and middle-income countries (LMICs) (China, Ethiopia, India, Nepal, and Tunisia). The Indigo Partnership aims to: (1) carry out research to strengthen the understanding of mechanisms of stigma processes and reduce stigma and discrimination against people with mental health conditions in LMICs; and (2) establish a strong collaborative research consortium through the conduct of this programme. Specifically, the Indigo Partnership involves developing and pilot testing anti-stigma interventions at the community, primary care, and mental health specialist care levels, with a systematic approach to cultural and contextual adaptation across the sites. This work also involves transcultural translation and adaptation of stigma and discrimination measurement tools. The Indigo Partnership operates with the key principle of partnering with people with lived experience of mental health conditions for the development and implementation of the pilot interventions, as well as capacity building and cross-site learning to actively develop a more globally representative and equitable mental health research community. This work is envisioned to have a long-lasting impact, both in terms of the capacity building provided to participating institutions and researchers, and the foundation it provides for future research to extend the evidence base of what works to reduce and ultimately end stigma and discrimination in mental health.
U2 - 10.1186/s13033-022-00564-5
DO - 10.1186/s13033-022-00564-5
M3 - Article
SN - 1752-4458
VL - 17
JO - International Journal of Mental Health Systems
JF - International Journal of Mental Health Systems
IS - 1
M1 - 2
ER -